{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:58:58Z","timestamp":1782871138908,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,11,5]],"date-time":"2003-11-05T00:00:00Z","timestamp":1067990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00296-003-0400-6","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T15:29:40Z","timestamp":1079710180000},"page":"1-5","source":"Crossref","is-referenced-by-count":49,"title":["Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Nur\u015fen","family":"D\u00fczg\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergin","family":"Aya\u015flio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Tutkak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay T.","family":"Aydintu\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,11,5]]},"reference":[{"key":"400_CR1","first-page":"1152","volume":"36","author":"Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) \u00dcber rezidivierende Aphthose, durch ein Virus verursachte Geschw\u00fcre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 36:1152\u20131157","journal-title":"Dermatol Wochenschr"},{"key":"400_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00002281-199401000-00007","volume":"6","author":"O\u2019Duffy","year":"1994","unstructured":"O\u2019Duffy JD (1994) Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 6:39\u201343","journal-title":"Curr Opin Rheumatol"},{"key":"400_CR3","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.87.8.3127","volume":"87","author":"Brockhaus","year":"1990","unstructured":"Brockhaus M, Shonfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines monoclonal antibodies. Proc Natl Acad Sci U S A 87:3127\u20133131","journal-title":"Proc Natl Acad Sci U S A"},{"key":"400_CR4","unstructured":"Arend WP (2002) The mode of action of cytokine inhibitors. J Rheumatol 29 [Suppl\u00a065]:16\u201321"},{"key":"400_CR5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(08)60535-0","volume":"54","author":"Arend","year":"1993","unstructured":"Arend WP (1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167\u2013227","journal-title":"Adv Immunol"},{"key":"400_CR6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/art.1780370507","volume":"37","author":"Firestein","year":"1994","unstructured":"Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644\u2013652","journal-title":"Arthritis Rheum"},{"key":"400_CR7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.1780351008","volume":"35","author":"Cope","year":"1992","unstructured":"Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC et al (1992) Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 35:1160\u20131169","journal-title":"Arthritis Rheum"},{"key":"400_CR8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780360812","volume":"36","author":"Aderka","year":"1993","unstructured":"Aderka D, Wysenbeek A, Engelman H, Cop AP, Brenanan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M et al (1993) Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 36:1111\u20131120","journal-title":"Arthritis Rheum"},{"key":"400_CR9","doi-asserted-by":"crossref","unstructured":"Rooney M, Varsani H, Martin K, Lombard PR, Dayer JM, Woo P (2000) Tumor necrosis factor alpha and its soluble receptors in juvenile chronic arthritis. Rheumatology (Oxford) 39:432\u2013438","DOI":"10.1093\/rheumatology\/39.4.432"},{"key":"400_CR10","first-page":"33","volume":"Med","author":"Nasonov","year":"2001","unstructured":"Nasonov EL, Chichasanova NV, Samsanova MIU, Tilz GP, Niki Foravo EL, Stepanets OV, Nasonova MB, Fuks D (2001) Soluble receptors of TNF-alpha in rheumatoid arthritis. Klin Med (Mosck) 79:33\u201336","journal-title":"Klin"},{"key":"400_CR11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/art.1780380806","volume":"38","author":"Suzuki","year":"1995","unstructured":"Suzuki Y, Takemura H, Kashiwagi H (1995) Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum 38:1055\u20131059","journal-title":"Arthritis Rheum"},{"key":"400_CR12","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.1780371206","volume":"37","author":"Gabay","year":"1994","unstructured":"Gabay C, Gay Croisier F, Roux Lombard P et al (1994) Elevated serum levels of interleukin-1 receptor antagonist in polymyositis\/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum 37:1744\u20131751","journal-title":"Arthritis Rheum"},{"key":"400_CR13","first-page":"345","volume":"31","author":"Yosipovitch","year":"1995","unstructured":"Yosipovitch YG, Shohat B, Bshara J, Wysenbeek A, Weinberger A (1995) Elevated serum interleukin-2 receptors and interleukin-I\u03b2 in patients with Beh\u00e7et\u2019s disease: correlations with disease activity and severity. Isr J Med Sci 31:345\u2013348","journal-title":"Isr J Med Sci"},{"key":"400_CR14","first-page":"128","volume":"24","author":"Turan","year":"1997","unstructured":"Turan B, Galati H, Erdi H, G\u00fcrler A, Michel BA, Villiger PM (1997) Systemic levels of T cell regulatory cytokines IL-10 and IL-12 in Beh\u00e7et\u2019s disease: soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24:128\u2013132","journal-title":"J Rheumatol"},{"key":"400_CR15","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"400_CR16","unstructured":"Dinarello CA (1995) Interleukin-1 and interleukin-1 receptor antagonist. Nutrition 11 [Suppl\u00a05]:492\u2013494"},{"key":"400_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","volume":"107","author":"Yamashita","year":"1997","unstructured":"17 Yamashita N, Kaneoka H, Kaneko S et al (1997) Role of gammadelta T lymphocytes in the development of Beh\u00e7et\u2019s disease. Clin Exp Immunol 107:241\u2013247","journal-title":"Clin Exp Immunol"},{"key":"400_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","volume":"1118","author":"Freysdotter","year":"1999","unstructured":"Freysdotter J, Lau S, Fortune F (1999) Gamma-delta T cells in Beh\u00e7et\u2019s disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1118:451\u2013457","journal-title":"Clin Exp Immunol"},{"key":"400_CR19","first-page":"321","volume":"23","author":"Sayinalp","year":"1996","unstructured":"Sayinalp N, \u00d6zcebe OI, \u00d6zdemir O, Haznedaro\u011flu IC, D\u00fcndar S, Kirazli S (1996) Cytokines in Beh\u00e7et\u2019s disease. J Rheumatol 23:321\u2013322","journal-title":"J Rheumatol"},{"key":"400_CR20","first-page":"1107","volume":"17","author":"Ako\u011flu","year":"1990","unstructured":"Ako\u011flu TF, Direskeneli H, Yaz\u0131c\u0131 H, Lawrence R (1990) TNF, soluble IL-2R and soluble CD-8 in Beh\u00e7et\u2019s disease [letter]. J Rheumatol 17:1107\u20131113","journal-title":"J Rheumatol"},{"key":"400_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"Evreklio\u011flu","year":"2002","unstructured":"Evreklio\u011flu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-\u03b1, sIL-2R, IL-6 and IL-8 are increased and associated with elevated lipid peroxidation in patients with Beh\u00e7et\u2019s disease. Mediators Inflamm 11:87\u201393","journal-title":"Mediators Inflamm"},{"key":"400_CR22","first-page":"1428","volume":"17","author":"Hamzaoui","year":"1990","unstructured":"Hamzaoui K, Hamza M, Ayed K (1990) Production of TNF-\u03b1 and IL-1 in active Beh\u00e7et\u2019s disease. J Rheumatol 17:1428\u20131429","journal-title":"J Rheumatol"},{"key":"400_CR23","first-page":"1544","volume":"20","author":"MegeJL,","year":"1993","unstructured":"MegeJL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte-derived tumor necrosis factor alpha, interleukin (IL)-6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544\u20131549","journal-title":"J Rheumatol"},{"key":"400_CR24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2249.2000.01176.x","volume":"120","author":"Kurhan-Yavuz","year":"2000","unstructured":"Kurhan-Yavuz S, Direskeneli H, Bozkurt N et al (2000) Anti-MHC autoimmunity in Beh\u00e7et\u2019s disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol 120:162\u2013166","journal-title":"Clin Exp Immunol"},{"key":"400_CR25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-3083.1988.tb02404.x","volume":"27","author":"Molvig","year":"1988","unstructured":"Molvig J, Baek J, Christensen P, Manogue KR, Vlassara H, Platz P et al (1988) Endotoxin-stimulated human monocyte secretion of interleukin-1, tumor necrosis factor alpha and prostoglandin E2 shows stable inter-individual differences. Scand J Immunol 27:705\u2013716","journal-title":"Scand J Immunol"},{"key":"400_CR26","unstructured":"Arend WP (2002) The mode of action of cytokine inhibitors. J Rheumatol 29 [Suppl\u00a065]:16\u201321"},{"key":"400_CR27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","volume":"160","author":"Peschon","year":"1998","unstructured":"Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR (1998) TNF receptor deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160:943\u2013952","journal-title":"J Immunol"},{"key":"400_CR28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0889-857X(05)70029-6","volume":"24","author":"Bresnihan","year":"1998","unstructured":"Bresnihan B, Cunnane G (1998) Interleukin-1 receptor antogonist. Rheumatol Dis Clin North Am 24:615","journal-title":"Rheumatol Dis Clin North Am"},{"key":"400_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00262712","volume":"15","author":"Ayd\u0131ntu\u011f","year":"1995","unstructured":"Ayd\u0131ntu\u011f AO, Tokg\u00f6z G, \u00d6zoran K, D\u00fczg\u00fcn N, G\u00fcrler A, Tutkak H (1995) Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Beh\u00e7et\u2019s disease. Rheumatol Int 15:75\u201378","journal-title":"Rheumatol Int"},{"key":"400_CR30","unstructured":"Memi\u015fo\u011flu H, Aksu HSZ, Erken E, G\u00f6c\u00fck M (1991) Serum interleukin-1 level in Beh\u00e7et\u2019s disease. In: O\u2019Duffy JD, K\u00f6kmen E (eds) Beh\u00e7et\u2019s disease. Dekker, New York, pp\u00a0387\u2013391"},{"key":"400_CR31","unstructured":"Treudler R, Ketteler R, Orfanos CE, Zouboulis CC (1997) Increased serum levels of interleukin I-beta and basic fibroblast growth factor in severe Adamandiades-Beh\u00e7et\u2019s disease. In: Hamzaou M (ed) Beh\u00e7et\u2019s disease. Tunis, pp\u00a033\u201337"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-003-0400-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-003-0400-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-003-0400-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:26:53Z","timestamp":1682656013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-003-0400-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1007\/s00296-003-0400-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,5]]}}}